Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16672225rdf:typepubmed:Citationlld:pubmed
pubmed-article:16672225lifeskim:mentionsumls-concept:C0018787lld:lifeskim
pubmed-article:16672225lifeskim:mentionsumls-concept:C0028778lld:lifeskim
pubmed-article:16672225lifeskim:mentionsumls-concept:C0001128lld:lifeskim
pubmed-article:16672225lifeskim:mentionsumls-concept:C0001480lld:lifeskim
pubmed-article:16672225lifeskim:mentionsumls-concept:C0441472lld:lifeskim
pubmed-article:16672225lifeskim:mentionsumls-concept:C0075586lld:lifeskim
pubmed-article:16672225lifeskim:mentionsumls-concept:C0287683lld:lifeskim
pubmed-article:16672225lifeskim:mentionsumls-concept:C0439799lld:lifeskim
pubmed-article:16672225lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:16672225pubmed:issue28lld:pubmed
pubmed-article:16672225pubmed:dateCreated2006-7-10lld:pubmed
pubmed-article:16672225pubmed:abstractTextDuring cardiac ischemia, ATP stores are depleted, and cardiomyocyte intracellular pH lowers to <7.0. The acidic pH acts on the Kir6.2 subunit of K(ATP) channels to reduce its sensitivity to ATP, causing channel opening. We recently reported that syntaxin-1A (Syn-1A) binds nucleotide binding folds (NBF)-1 and NBF2 of sulfonylurea receptor 2A (SUR2A) to inhibit channel activity (Kang, Y., Leung, Y. M., Manning-Fox, J. E., Xia, F., Xie, H., Sheu, L., Tsushima, R. G., Light, P. E., and Gaisano, H. Y. (2004) J. Biol. Chem. 279, 47125-47131). Here, we examined Syn-1A actions on SUR2A to influence the pH regulation of cardiac K(ATP) channels. K(ATP) channel currents from inside-out patches excised from Kir6.2/SUR2A expressing HEK293 cells and freshly isolated cardiac myocytes were increased by reducing intracellular pH from 7.4 to 6.8, which could be blocked by increasing concentrations of Syn-1A added to the cytoplasmic surface. Syn-1A had no effect on C-terminal truncated Kir6.2 (Kir6.2-deltaC26) channels expressed in TSA cells without the SUR subunit. In vitro binding and co-immunoprecipitation studies show that Syn-1A binding to SUR2A or its NBF-1 and NBF-2 domain proteins increased progressively as pH was reduced from 7.4 to 6.0. The enhancement of Syn-1A binding to SUR2A by acidic pH was further regulated by Mg2+ and ATP. Therefore, pH regulates Kir.6.2/SUR2A channels not only by its direct actions on the Kir6.2 subunit but also by modulation of Syn-1A binding to SUR2A. The increased Syn-1A binding to the SUR2A at acidic pH would assert some inhibition of the K(ATP) channels, which may serve as a "brake" to temper the fluctuation of low pH-induced K(ATP) channel opening that could induce fatal reentrant arrhythmias.lld:pubmed
pubmed-article:16672225pubmed:languageenglld:pubmed
pubmed-article:16672225pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16672225pubmed:citationSubsetIMlld:pubmed
pubmed-article:16672225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16672225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16672225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16672225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16672225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16672225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16672225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16672225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16672225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16672225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16672225pubmed:statusMEDLINElld:pubmed
pubmed-article:16672225pubmed:monthJullld:pubmed
pubmed-article:16672225pubmed:issn0021-9258lld:pubmed
pubmed-article:16672225pubmed:authorpubmed-author:BertoEElld:pubmed
pubmed-article:16672225pubmed:authorpubmed-author:TinkerAndrewAlld:pubmed
pubmed-article:16672225pubmed:authorpubmed-author:TsushimaRober...lld:pubmed
pubmed-article:16672225pubmed:authorpubmed-author:GaisanoHerber...lld:pubmed
pubmed-article:16672225pubmed:authorpubmed-author:KangYouhouYlld:pubmed
pubmed-article:16672225pubmed:authorpubmed-author:HeYanYlld:pubmed
pubmed-article:16672225pubmed:authorpubmed-author:LodwickDavidDlld:pubmed
pubmed-article:16672225pubmed:authorpubmed-author:XieHuanliHlld:pubmed
pubmed-article:16672225pubmed:authorpubmed-author:NormanRobert...lld:pubmed
pubmed-article:16672225pubmed:authorpubmed-author:LeungYuk-ManY...lld:pubmed
pubmed-article:16672225pubmed:issnTypePrintlld:pubmed
pubmed-article:16672225pubmed:day14lld:pubmed
pubmed-article:16672225pubmed:volume281lld:pubmed
pubmed-article:16672225pubmed:ownerNLMlld:pubmed
pubmed-article:16672225pubmed:authorsCompleteYlld:pubmed
pubmed-article:16672225pubmed:pagination19019-28lld:pubmed
pubmed-article:16672225pubmed:dateRevised2008-9-27lld:pubmed
pubmed-article:16672225pubmed:meshHeadingpubmed-meshheading:16672225...lld:pubmed
pubmed-article:16672225pubmed:meshHeadingpubmed-meshheading:16672225...lld:pubmed
pubmed-article:16672225pubmed:meshHeadingpubmed-meshheading:16672225...lld:pubmed
pubmed-article:16672225pubmed:meshHeadingpubmed-meshheading:16672225...lld:pubmed
pubmed-article:16672225pubmed:meshHeadingpubmed-meshheading:16672225...lld:pubmed
pubmed-article:16672225pubmed:meshHeadingpubmed-meshheading:16672225...lld:pubmed
pubmed-article:16672225pubmed:meshHeadingpubmed-meshheading:16672225...lld:pubmed
pubmed-article:16672225pubmed:meshHeadingpubmed-meshheading:16672225...lld:pubmed
pubmed-article:16672225pubmed:meshHeadingpubmed-meshheading:16672225...lld:pubmed
pubmed-article:16672225pubmed:meshHeadingpubmed-meshheading:16672225...lld:pubmed
pubmed-article:16672225pubmed:meshHeadingpubmed-meshheading:16672225...lld:pubmed
pubmed-article:16672225pubmed:meshHeadingpubmed-meshheading:16672225...lld:pubmed
pubmed-article:16672225pubmed:meshHeadingpubmed-meshheading:16672225...lld:pubmed
pubmed-article:16672225pubmed:meshHeadingpubmed-meshheading:16672225...lld:pubmed
pubmed-article:16672225pubmed:meshHeadingpubmed-meshheading:16672225...lld:pubmed
pubmed-article:16672225pubmed:meshHeadingpubmed-meshheading:16672225...lld:pubmed
pubmed-article:16672225pubmed:year2006lld:pubmed
pubmed-article:16672225pubmed:articleTitleSyntaxin-1A actions on sulfonylurea receptor 2A can block acidic pH-induced cardiac K(ATP) channel activation.lld:pubmed
pubmed-article:16672225pubmed:affiliationDepartment of Medicine, University of Toronto, Toronto, Canada M5S 1A8.lld:pubmed
pubmed-article:16672225pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16672225pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:6804entrezgene:pubmedpubmed-article:16672225lld:entrezgene
entrez-gene:10060entrezgene:pubmedpubmed-article:16672225lld:entrezgene
entrez-gene:25560entrezgene:pubmedpubmed-article:16672225lld:entrezgene
entrez-gene:116470entrezgene:pubmedpubmed-article:16672225lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16672225lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16672225lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16672225lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16672225lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16672225lld:pubmed